NCCN Guidelines for Patients® | Multiple Myeloma - page 76

NCCN Guidelines for Patients™: Multiple Myeloma
Version 1.2012
Part 8: Dictionary
Recurrence (recur)
The return of cancer after treatment.
Red blood cell
A type of blood cell that carries
oxygen from the lungs to all parts of
the body.
Red marrow
The soft tissue in the center of most
bones where blood cells are formed.
A treatment plan that specifies the
dosage, schedule, and duration of
Regional anesthesia
A controlled temporary loss of feeling
or awareness in a part of the body
without loss of wakefulness.
The return of cancer after a period of
Salvage therapy
Treatment that is given after
cancer has not responded to other
Serum free light chain assay
A blood test that measures the
fragments of the proteins made
by myeloma cells.
Serum immunofixation
electrophoresis (SIFE)
A test used to identify the type of
M-proteins in the blood.
Serum protein electrophoresis
A test that measures the amount of
M-proteins in the blood.
Serum quantitative
A test that measures the amount of
each class of antibodies in the blood.
Serum viscosity
A test that measures the thickness of
Side effect
An unplanned physical or emotional
response to treatment.
Single agent
The use of one drug.
Skeletal survey
A series of x-rays of the skeleton to
look for bone damage. Also called
bone survey.
Smoldering myeloma
Myeloma that isn’t causing symptoms
or damaging organs.
The bones, muscles, and other
tissues along the back from the base
of the skull to the tailbone.
A device used to support a broken
bone and hold it in place.
Stable disease
Cancer that is not getting worse or
better in terms of extent or severity.
Standard care
The process that a health professional
should follow to treat a medical
Stem cell
An immature cell from which other
types of cells develop.
1...,66,67,68,69,70,71,72,73,74,75 77,78,79,80,81,82,83,84
Powered by FlippingBook